CUV 0.85% $15.37 clinuvel pharmaceuticals limited

"Waiting for the right time I expect." This might have been...

  1. 867 Posts.
    lightbulb Created with Sketch. 236
    "Waiting for the right time I expect."

    This might have been answered in the announcement. Perhaps what PW/CUV are saying is that 'yes, we could have gone for VP earlier with a label extension, however, we wanted to extend the market exclusivity of Scenesse as fully as possible and not overlap much or any of that additional 10 years with the current market exclusivity relating to EPP'.

    While PW has possibly been hung, drawn and quartered in the past for the delays in dealing with the VP extension (and possibly XP for that matter), perhaps the reason is strategic and this could be part of that long term strategy playing out and why PW has always appeared relaxed over exclusivity periods?
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.37
Change
0.130(0.85%)
Mkt cap ! $770.0M
Open High Low Value Volume
$15.36 $15.54 $15.18 $1.274M 82.63K

Buyers (Bids)

No. Vol. Price($)
1 237 $15.31
 

Sellers (Offers)

Price($) Vol. No.
$15.50 282 2
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.